230 related articles for article (PubMed ID: 7586635)
1. Hepatocellular carcinoma: update on diagnosis and treatment.
Ramsey WH; Wu GY
Dig Dis; 1995; 13(2):81-91. PubMed ID: 7586635
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels.
Kang SH; Kim DY; Jeon SM; Ahn SH; Park JY; Kim SU; Kim JK; Lee KS; Chon CY; Han KH
Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):849-56. PubMed ID: 22495400
[TBL] [Abstract][Full Text] [Related]
3. Early detection of recurrent hepatocellular carcinoma.
Nishizaki T; Takenaka K; Yanaga K; Soejima Y; Uchiyama H; Kishikawa K; Sugimachi K
Hepatogastroenterology; 1997; 44(14):508-13. PubMed ID: 9164527
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of serum alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) levels in patients with hepatocellular carcinoma following interventional radiology.
Minakuchi K; Murata K; Kaminoh T; Takada K; Takashima S; Nakamura K; Onoyama Y
Radiat Med; 1993; 11(6):231-6. PubMed ID: 7512271
[TBL] [Abstract][Full Text] [Related]
5. [Hepatocellular carcinoma: Role of imaging diagnostics in detection, intervention and follow-up].
Vogl TJ; Eichler K; Zangos S; Mack M; Hammerstingl R
Rofo; 2002 Nov; 174(11):1358-68. PubMed ID: 12424661
[TBL] [Abstract][Full Text] [Related]
6. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
[TBL] [Abstract][Full Text] [Related]
7. Optimal treatment increased survival of hepatocellular carcinoma patients detected with community-based screening.
Tseng PL; Wang JH; Tung HD; Hung CH; Kee KM; Chen CH; Chang KC; Lee CM; Changchien CS; Chen PF; Tsai LS; Lu SN
J Gastroenterol Hepatol; 2010 Aug; 25(8):1426-34. PubMed ID: 20659234
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma in patients who undergo liver transplantation: sensitivity of CT with iodized oil.
Spreafico C; Marchianò A; Mazzaferro V; Frigerio LF; Regalia E; Lanocita R; Patelli G; Andreola S; Garbagnati F; Damascelli B
Radiology; 1997 May; 203(2):457-60. PubMed ID: 9114104
[TBL] [Abstract][Full Text] [Related]
9. [Tumor markers for hepatocellular carcinoma].
Tateishi R; Enooku K; Shiina S; Koike K
Nihon Rinsho; 2012 May; 70(5):821-7. PubMed ID: 22620007
[TBL] [Abstract][Full Text] [Related]
10. [Clinical characteristics of hepatocellular carcinoma in patients with antibody to hepatitis C virus].
Nagoshi S; Fujiwara K
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):615-8. PubMed ID: 15359871
[No Abstract] [Full Text] [Related]
11. Ultrasound-guided fine needle biopsy of intrahepatic nodules and low elevation of AFP in early diagnosis of hepatocellular carcinoma.
He YM; Wang XY; Gao SD; Yu LY; Lin XD; Lin LW
Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):50-4. PubMed ID: 15730919
[TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation of PIVKA-II as a marker of hepatocellular carcinoma].
Arima K; Kodama T; Suga M; Sakamoto H; Ohe Y; Yachi A
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):3049-52. PubMed ID: 2476968
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of hepatocellular carcinoma in the cirrhotic liver].
Hourmand-Ollivier I; Chiche L
J Chir (Paris); 2004 Mar; 141(2):71-83. PubMed ID: 15133430
[TBL] [Abstract][Full Text] [Related]
14. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
Yamamoto K; Imamura H; Matsuyama Y; Hasegawa K; Beck Y; Sugawara Y; Makuuchi M; Kokudo N
Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841
[TBL] [Abstract][Full Text] [Related]
15. Sensitive measurement of serum abnormal prothrombin (PIVKA-II) as a marker of hepatocellular carcinoma.
Tanaka Y; Kashiwagi T; Tsutsumi H; Nagasawa M; Toyama T; Ozaki S; Naito M; Ishibashi K; Azuma M
Hepatogastroenterology; 1999; 46(28):2464-8. PubMed ID: 10522021
[TBL] [Abstract][Full Text] [Related]
16. Time courses of PIVKA-II and AFP levels after hepatic artery embolization and hepatic artery infusion against hepatocellular carcinoma: relation between the time course and tumor necrosis.
Kishi K; Sonomura T; Mitsuzane K; Nishida N; Kimura M; Satoh M; Yamada R; Kodama N; Kinoshita M; Tanaka H
Radiat Med; 1992; 10(5):189-95. PubMed ID: 1279748
[TBL] [Abstract][Full Text] [Related]
17. [Imaging techniques in hepatocellular carcinoma: diagnosis, extension and evaluation of therapeutic response].
Ayuso C; Rimola J; Forner A
Gastroenterol Hepatol; 2010 Dec; 33(10):721-6. PubMed ID: 20447736
[TBL] [Abstract][Full Text] [Related]
18. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A
Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
[TBL] [Abstract][Full Text] [Related]
19. [Early diagnosis of hepatocellular carcinoma].
Hirooka N; Matsuura N; Ohto M
Nihon Rinsho; 1994 Jan; 52(1):69-74. PubMed ID: 7509420
[TBL] [Abstract][Full Text] [Related]
20. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
